XML 147 R127.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Compensation - Summary of Share Based Compensation Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Granted, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 41.75 $ 64.61 $ 72.54
SARs and Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding at Beginning, Number (in shares) 1,367    
Granted, Number (in shares) 149    
Exercised or converted, Number (in shares) (38)    
Forfeited or expired, Number (in shares) (167)    
Outstanding at Ending, Number (in shares) 1,311 1,367  
Vested or expected to vest at End, Number (in shares) 1,266    
Exercisable or convertible at End, Number (in shares) 1,021    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]      
Outstanding at Beginning, Weighted-Average Exercise Price (in dollars per share) $ 65.04    
Granted, Weighted-Average Exercise Price (in dollars per share) 51.14    
Exercised or converted, Weighted-Average Exercise Price (in dollars per share) 38.24    
Forfeited or expired, Weighted-Average Exercise Price (in dollars per share) 66.42    
Outstanding at End, Weighted-Average Exercise Price (in dollars per share) 64.06 $ 65.04  
Vested or expected to vest at End, Weighted-Average Exercise Price 64.09    
Exercisable or convertible at End, Weighted-Average Exercise Price $ 62.62    
Outstanding at End, Weighted-Average Remaining Contractual Term 5 years 8 months 12 days    
Vested or expected to vest at End, Weighted-Average Remaining Contractual Term 5 years 8 months 12 days    
Exercisable or convertible at End, Weighted-Average Remaining Contractual Term 5 years 6 months    
Outstanding at End, Aggregate Intrinsic Value $ (29,054)    
Vested or expected to vest at End, Aggregate Intrinsic Value (28,096)    
Exercisable or convertible at End, Aggregate Intrinsic Value $ (24,060)    
Restricted Shares and Units      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Outstanding at Beginning, Number (in shares) 737    
Granted, Number (in shares) 565    
Exercised or converted, Number (in shares) (102)    
Forfeited or expired, Number (in shares) (247)    
Outstanding at End, Number (in shares) 953 737  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Outstanding at Beginning, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 68.31    
Granted, Weighted-Average Grant-Date Fair Value (in dollars per share) 41.75    
Exercised or converted, Weighted-Average Grant-Date Fair Value (in dollars per share) 64.56    
Forfeited or expired, Weighted-Average Grant-Date Fair Value (in dollars per share) 75.07    
Outstanding at End, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 52.50 $ 68.31